Dermapharm AG

Dermapharm AG develops and supplies pharmaceuticals, medical products and medical cosmetics. Its product portfolio addresses health, skin care, allergies, environmental influences and cortisone-related treatments, with prescription and non-prescription products available. Named products include Dekristolvit vitamin D products, Keltican forte for peripheral nerve regeneration support, Minoxicutan containing minoxidil, Ketozolin for dandruff and itching, Tromcardin complex with electrolytes and vitamin B1, and the herpotherm neo herpes heat pen. The company also offers topical dermatological products and patient information materials.

The company focuses on developing new galenic dosage forms and bringing products with distinct therapeutic propositions to market. It positions its range around the requirements of doctors, pharmacists and patients within the healthcare system, while maintaining a particular role as a skin specialist. Production and development take place in Germany through the wider Dermapharm Group. Group-wide governance, risk and compliance standards cover legal and regulatory compliance, risk monitoring, internal controls, employee training, reporting and investigations. A Code of Conduct guides employee activities and decisions, and a whistleblowing channel enables confidential reporting of potential legal, human rights or environmental violations.